Flores, Rosamia N.

HRN: 13-79-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2024
11/13/2024
IV
600mg
Q8
Cellulitis
Waiting Final Action 
10/30/2024
CEFTRIAXONE 1G (VIAL)
10/30/2024
11/06/2024
IV
2g
OD
Cellulitis
Waiting Final Action 
10/31/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/31/2024
11/13/2024
IV
500
Q8
Cellulitis
Waiting Final Action 
10/31/2024
MUPIROCIN 2%, 15G (TUBE)
10/31/2024
11/06/2024
TOPICAL
2%
Bid
Cellulitis
Waiting Final Action 
11/08/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/08/2024
11/15/2024
IV
1.5g
Q8
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: